Richard H. J. Beǵent

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

Mark Bower, E.S. Newlands, L. Holden et al. · Journal of Clinical Oncology · 1997 · 311 citations

Medicine, Gynecology, Oncology +17

Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library

Richard H. J. Beǵent, Marlies J. Verhaar, Kerry Chester et al. · Nature Medicine · 1996 · 242 citations

Pharmacy, Immunology, Oncology +17

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

D.B. Smith, ES Newlands, Gordon Rustin et al. · The Lancet · 1991 · 211 citations

Medicine, Oncology, Pharmacology +8

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

Nicholas C. Turner, Sandra J. Strauss, Debashis Sarker et al. · British Journal of Cancer · 2010 · 194 citations · Full text

Medicine, Oncology, Pharmacology +13

Central nervous system metastases of choriocarcinoma. 23 Years' experience at Charing Cross Hospital

A. Athanassiou, Richard H. J. Beǵent, E.S. Newlands et al. · Cancer · 1983 · 183 citations

Medicine, Neurosurgery, Oncology +11